Marcin Piersiak

Marcin Piersiak

Auto-generated profile, based on publicly available information

Marcin Piersiak

4th Military Clinical Hospital with Polyclinic in Wrocław

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
KSKatarzyna Słychan
Katarzyna Słychan
MPMarcin Piersiak
Marcin Piersiak
JRJakub Rubin
Jakub Rubin
AKAleksandra Kozioł
Aleksandra Kozioł
MTMichał Tyliszczak
Michał Tyliszczak
RCRafal Chojak
Rafal Chojak

Verified
Journal Article
Open access
PDF file
MSMałgorzata Szymala-Pędzik
Małgorzata Szymala-Pędzik
MPMarcin Piersiak
Marcin Piersiak
MPMaciej Pachana
Maciej Pachana
KLKarolina Lindner-Pawłowicz
Karolina Lindner-Pawłowicz
WSWioletta Szczepaniak
Wioletta Szczepaniak
MSMałgorzata Sobieszczańska
Małgorzata Sobieszczańska
Background/Objectives: Fatty liver disease (FLD) is currently the most common liver disorder, affecting 25–30% of the global population. Its occurrence is strongly associated with overweight, obesity, and type 2 diabetes. In 2020, the disease definition was revised from NAFLD (non-alcoholic fatty liver disease) to MAFLD (metabolic-associated fatty liver disease), emphasizing its link to metabolic dysfunction and marking a major shift in clinical evaluation and risk stratification. We assessed the association between MAFLD and cardiovascular risk factors in a geriatric population by comparing patients with and without fatty liver disease and evaluating the influence of selected metabolic and echocardiographic parameters on MAFLD prevalence. Methods: This retrospective study was conducted using data from patients treated at the Department of Geriatrics, the University Clinical Hospital, in Wrocław. The study included 237 patients diagnosed with fatty liver disease and 148 controls without liver pathology. The groups were compared in terms of comorbidities, laboratory abnormalities, body mass index (BMI), and left ventricular hypertrophy. Statistical analysis was performed to assess the association between the severity of selected variables and the risk of MAFLD. Results: Patients with MAFLD had significantly higher body weight and BMI compared to controls. Diabetes mellitus and hypertriglyceridemia were more frequent in the MAFLD group, whereas HDL and vitamin D3 levels were lower. Echocardiographic indicators of left ventricular hypertrophy [IVSd, LVPWd, (IVSd + LVPWd)/2] were significantly elevated in MAFLD patients. Conclusions: This study confirms a strong association between MAFLD and cardiovascular risk factors in elderly patients. The inclusion of a control group allowed for more precise evaluation, supporting the role of MAFLD as an independent cardiometabolic risk indicator in geriatric care.

12 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MPMaciej Pachana
Maciej Pachana
PKPiotr Kukuła
Piotr Kukuła
MZMaciej Ziomek
Maciej Ziomek
MPMarcin Piersiak
Marcin Piersiak
HSHubert Sawczuk
Hubert Sawczuk
JMJulia Marschollek
Julia Marschollek
Ankle sprains, particularly lateral sprains involving the anterior talofibular ligament (ATFL), represent up to 85% of ankle injuries and are common in both athletic and general populations. Despite their prevalence, misdiagnosis and inadequate treatment can lead to chronic ankle instability and post-traumatic osteoarthritis. This narrative review synthesizes current clinical guidelines and evidence-based practices for diagnosis and treatment. Clinical assessment, supported by the Ottawa Ankle Rules, ultrasound, and MRI, enables accurate injury classification. Conservative treatment is preferred for Grade I and II injuries, with early mobilization and functional support—especially within the POLICE protocol—demonstrating superior outcomes. Exercise therapy effectively reduces recurrence, while surgical intervention is reserved for Grade III injuries or chronic instability in high-demand patients. Timely and structured rehabilitation remains key to restoring ankle function.

12 November 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MPMaciej Pachana
Maciej Pachana
MPMarcin Piersiak
Marcin Piersiak
HSHubert Sawczuk
Hubert Sawczuk
ATAnna Tomasiewicz
Anna Tomasiewicz
JZJan Zabierowski
Jan Zabierowski
MZMaciej Ziomek
Maciej Ziomek
Mammography is a critical tool in breast cancer screening and secondary prevention, enabling early detection and significantly reducing breast cancer mortality. This literature review assesses the effectiveness of mammography in identifying early-stage tumors, discussing its advantages, limitations, and specific challenges. Additionally, advancements in imaging techniques, such as 3D tomosynthesis, are examined, especially for their enhanced sensitivity in women with dense breast tissue, which reduces structural overlap and improves diagnostic precision. The integration of artificial intelligence (AI) in mammographic image analysis opens new opportunities, supporting radiologists by automating the detection and classification of potential lesions, thereby increasing screening efficiency and reducing false-positive rates. However, effective implementation of AI requires seamless integration with clinical systems and ongoing research to refine algorithms for diverse clinical needs. Furthermore, legal frameworks are essential to delineate responsibility in AI-supported diagnostics. This review emphasizes the status of breast cancer screening in Poland, where participation rates remain low despite the availability of free screenings. This highlights the need for improved public awareness and accessibility, especially in underserved areas. Overall, the findings underscore the fundamental role of mammography in breast cancer detection, with AI and other technological advancements significantly enhancing diagnostic accuracy while identifying areas for further improvement.

29 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ATAnna Tomasiewicz
Anna Tomasiewicz
JZJan Zabierowski
Jan Zabierowski
MPMaciej Pachana
Maciej Pachana
PKPiotr Kukuła
Piotr Kukuła
MPMarcin Piersiak
Marcin Piersiak
MZMaciej Ziomek
Maciej Ziomek
In recent years a steady increase in the prevalence of obesity has caused a growing interest in pharmacological anti-obesity treatment, including semaglutide, glucagon-like peptide-1 (GLP-1) receptor agonist, which has been proven effective in inducing weight loss in obese patients. However, due to rapid growth of its popularity, monitoring and updatig of guidelines and potential adverse effects may have been outpaced. One of the adverse effects taken into consideration is semaglutide’s impact on reduction of lean mass, fat-free mass and muscle mass. Available studies, although not unanimous, indicate that although decrease of lean mass occurs alongside loss of fat mass, proportion of lean mass increases. Moreover, some studies suggest that semaglutide treatment has a positive impact on muscle function. Nevertheless, the search for strategies allowing for mitigation of lean mass loss during this treatment is still necessary, particularly considering groups of patients at risk of such a complication. Two approaches are being considered: lifestyle interventions and pharmacological treatment. Studies suggest that resistance exercise training interventions can elicit significant increases in lean mass during semaglutide treatment. When it comes to dietary interventions, there is significant need for research that would aim at identifying dietary factors promoting lean mass preservation in this population. Currently explored pharmacological support options include various human monoclonal antibodies (bimagrumab, trevogrumab, garetosumab). Introducing these drugs alongside semaglutide has promoted lean mass preservation despite fat mass loss. Currently existing studies should serve as a guide for further extensive research. At this time, it seems there are more questions than answers surrounding the issue of semaglutide’s impact on lean mass and strategies to mitigate its excess loss.

12 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JZJan Zabierowski
Jan Zabierowski
ATAnna Tomasiewicz
Anna Tomasiewicz
MPMaciej Pachana
Maciej Pachana
PKPiotr Kukuła
Piotr Kukuła
MPMarcin Piersiak
Marcin Piersiak
MZMaciej Ziomek
Maciej Ziomek
Background:Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While moderate physical activity is known to reduce AF risk, endurance athletes, particularly males, appear to have a higher prevalence of AF. The relationship between physical activity and AF follows a U-shaped curve, where both sedentary lifestyles and extreme-levels of physical activity increase the risk. Understanding the pathophysiology, risk factors, and management of AF in athletes is crucial for optimizing both cardiovascular health and athletic performance. Aim of the work:This study aims to review current literature on AF in athletes, focusing on its prevalence, pathophysiology, risk factors, gender differences, clinical significance, and management strategies. It also seeks to identify gaps in research and suggest future directions for improving prevention and treatment in this population. Materials and methods: A thorough literature review was conducted using databases such as PubMed and Google Scholar, covering studies from the last 20 years. Keywords included "atrial fibrillation," "athletes," "endurance sports," and "exercise-induced AF." Studies were selected based on relevance, methodology, and sample size. Results: Findings suggest that AF prevalence is significantly higher in endurance athletes, particularly in middle-aged men with long-term high-intensity training. Key contributing factors include atrial remodeling, inflammation, fibrosis and autonomic nervous system imbalance. While male athletes appear to be at greater risk, evidence in female athletes remains limited and inconclusive. Management strategies emphasize risk factor modification, individualized treatment plans, careful use of medications and ablation therapy. Exercise reduction as a preventive strategy remains debated.